- Home
- TECH vs RYAN Comparison
TECH vs RYAN Comparison
Compare TECH & RYAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- RYAN
- Stock Information
- Founded
- TECH 1976
- RYAN 2010
- Country
- TECH United States
- RYAN United States
- Employees
- TECH N/A
- RYAN N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- RYAN Specialty Insurers
- Sector
- TECH Health Care
- RYAN Finance
- Exchange
- TECH Nasdaq
- RYAN Nasdaq
- Market Cap
- TECH 8.3B
- RYAN 7.4B
- IPO Year
- TECH 1989
- RYAN 2021
- Fundamental
- Price
- TECH $52.88
- RYAN $52.86
- Analyst Decision
- TECH Buy
- RYAN Strong Buy
- Analyst Count
- TECH 12
- RYAN 12
- Target Price
- TECH $70.91
- RYAN $74.80
- AVG Volume (30 Days)
- TECH 2.1M
- RYAN 1.4M
- Earning Date
- TECH 10-29-2025
- RYAN 10-29-2025
- Dividend Yield
- TECH 0.62%
- RYAN 0.90%
- EPS Growth
- TECH N/A
- RYAN N/A
- EPS
- TECH 0.46
- RYAN N/A
- Revenue
- TECH $1,219,635,000.00
- RYAN $2,754,521,000.00
- Revenue This Year
- TECH $4.13
- RYAN $27.79
- Revenue Next Year
- TECH $7.56
- RYAN $16.67
- P/E Ratio
- TECH $112.02
- RYAN N/A
- Revenue Growth
- TECH 5.23
- RYAN 23.84
- 52 Week Low
- TECH $46.01
- RYAN $50.08
- 52 Week High
- TECH $80.95
- RYAN $77.16
- Technical
- Relative Strength Index (RSI)
- TECH 49.85
- RYAN 34.33
- Support Level
- TECH $50.96
- RYAN $50.79
- Resistance Level
- TECH $53.75
- RYAN $54.61
- Average True Range (ATR)
- TECH 1.74
- RYAN 1.33
- MACD
- TECH -0.20
- RYAN 0.08
- Stochastic Oscillator
- TECH 55.01
- RYAN 35.18
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About RYAN Ryan Specialty Holdings Inc.
Ryan Specialty Holdings Inc is a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It provides distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.